Adding diabetes drugs to methotrexate for rheumatoid arthritis
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study tests whether two diabetes medications, dapagliflozin and empagliflozin, can help reduce rheumatoid arthritis symptoms when added to your current methotrexate treatment. It may offer a new option for people whose arthritis is still active despite methotrexate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with rheumatoid arthritis.
- You have been taking methotrexate for at least 12 weeks and are still experiencing active symptoms.
- You are not pregnant or breastfeeding.
- You do not have severe kidney or liver problems, and you have not had recent urinary or genital infections.
- You are not currently taking a diabetes drug called an SGLT2 inhibitor, and you do not have type 1 diabetes or a history of diabetic ketoacidosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding empagliflozin to methotrexate helps reduce rheumatoid arthritis activity compared to methotrexate alone. It may protect joints from further damage.
This study tests whether desloratadine, an allergy medication, can help reduce rheumatoid arthritis symptoms when added to your current treatments. Researchers want to see if it reduces joint swelling and pain alongside your existing therapy.
This study tests whether adding roflumilast, a new medication, to your current rheumatoid arthritis treatment can help reduce joint inflammation and improve your symptoms. You would take it alongside methotrexate, a common RA medication you may already be using.
This trial tests whether adding silymarin (a natural supplement from milk thistle) to standard methotrexate treatment can improve symptoms of rheumatoid arthritis. It may help reduce joint pain and swelling for people who are not yet in remission.
This study compares two oral medications, tofacitinib and upadacitinib, when added to methotrexate for people with rheumatoid arthritis. The goal is to see which one works better and is safer for controlling symptoms.
This study tests a methotrexate injection (given under the skin) for people with moderate to severe rheumatoid arthritis who haven't taken methotrexate before. Researchers want to see how the medicine builds up in your body and if it helps control your symptoms.
Hear when a new Rheumatoid Arthritis (RA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.